Ashley Enstone

433 total citations
22 papers, 264 citations indexed

About

Ashley Enstone is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Ashley Enstone has authored 22 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Economics and Econometrics. Recurrent topics in Ashley Enstone's work include Influenza Virus Research Studies (4 papers), Respiratory viral infections research (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Ashley Enstone is often cited by papers focused on Influenza Virus Research Studies (4 papers), Respiratory viral infections research (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Ashley Enstone collaborates with scholars based in United Kingdom, United States and Switzerland. Ashley Enstone's co-authors include Bo Ding, Verna Welch, Alejandro Cané, Amit Srivastava, Yong Yuan, Santiago M. C. Lopez, John R. Penrod, Laura Puzniak, Tom Palmer and Mary M. Moran and has published in prestigious journals such as PLoS ONE, Health and Quality of Life Outcomes and Value in Health.

In The Last Decade

Ashley Enstone

20 papers receiving 261 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashley Enstone United Kingdom 11 149 47 45 45 39 22 264
Yuqian Chen China 10 112 0.8× 34 0.7× 26 0.6× 62 1.4× 33 0.8× 25 321
Shinya Hasegawa United States 11 72 0.5× 82 1.7× 19 0.4× 27 0.6× 13 0.3× 36 341
Alejandro Martín‐Quirós Spain 12 148 1.0× 130 2.8× 12 0.3× 34 0.8× 46 1.2× 33 450
Benjamin Hetzer Austria 11 108 0.7× 39 0.8× 7 0.2× 25 0.6× 46 1.2× 27 318
Seungjae Lee South Korea 5 56 0.4× 273 5.8× 12 0.3× 42 0.9× 31 0.8× 9 408
Davaalkham Dambadarjaa Mongolia 12 172 1.2× 36 0.8× 37 0.8× 13 0.3× 31 0.8× 33 325
Sae‐Rom Chae United States 7 59 0.4× 142 3.0× 6 0.1× 19 0.4× 43 1.1× 12 250
José-Antonio Navarro-Alonso Spain 10 156 1.0× 39 0.8× 39 0.9× 28 0.6× 32 0.8× 34 264
Victor Perez-Gutierrez United States 8 34 0.2× 40 0.9× 9 0.2× 96 2.1× 10 0.3× 15 264
Sarah Kristine Nørgaard Denmark 8 57 0.4× 37 0.8× 22 0.5× 25 0.6× 20 0.5× 17 220

Countries citing papers authored by Ashley Enstone

Since Specialization
Citations

This map shows the geographic impact of Ashley Enstone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Enstone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Enstone more than expected).

Fields of papers citing papers by Ashley Enstone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley Enstone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Enstone. The network helps show where Ashley Enstone may publish in the future.

Co-authorship network of co-authors of Ashley Enstone

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley Enstone. A scholar is included among the top collaborators of Ashley Enstone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley Enstone. Ashley Enstone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Langer, J, Verna Welch, Mary M. Moran, et al.. (2024). The Cost of Seasonal Influenza: A Systematic Literature Review on the Humanistic and Economic Burden of Influenza in Older (≥ 65 Years Old) Adults. Advances in Therapy. 41(3). 945–966. 12 indexed citations
3.
Smith, Terry J., et al.. (2024). Bridging and Validation of the Specific Graves Ophthalmopathy Quality of Life Questionnaire With Health State Utility Values. Endocrine Practice. 30(5). 470–475. 2 indexed citations
4.
Benedict, Ralph H. B., et al.. (2024). Disutility of Cognitive Processing Speed (CPS) Impairment in the Context of Multiple Sclerosis: A Time Trade-Off (TTO) Elicitation Study. ClinicoEconomics and Outcomes Research. Volume 16. 55–67.
5.
Welch, Verna, Mary M. Moran, Alejandro Cané, et al.. (2023). High Clinical Burden of Influenza Disease in Adults Aged ≥ 65 Years: Can We Do Better? A Systematic Literature Review. Advances in Therapy. 40(4). 1601–1627. 49 indexed citations
6.
Welch, Verna, et al.. (2023). Understanding the Global Burden of Influenza in Adults Aged 18–64 years: A Systematic Literature Review from 2012 to 2022. Advances in Therapy. 40(10). 4166–4188. 21 indexed citations
7.
Welch, Verna, Richard Macey, Ashley Enstone, et al.. (2023). Understanding the Barriers and Attitudes toward Influenza Vaccine Uptake in the Adult General Population: A Rapid Review. Vaccines. 11(1). 180–180. 41 indexed citations
8.
Enstone, Ashley, et al.. (2023). Elicitation of Health State Utility Values in Retinitis Pigmentosa by Time Trade-off in the United Kingdom. ClinicoEconomics and Outcomes Research. Volume 15. 29–39. 3 indexed citations
9.
Belger, Mark, et al.. (2022). PCR24 The Impact of Informal Caregiving in Alzheimer’s Disease Dementia: A Health Utility Study in the UK. Value in Health. 25(7). S545–S545. 1 indexed citations
10.
Smith, Terry J., et al.. (2022). Utility Assessment of Moderate to Severe Thyroid Eye Disease Health States. JAMA Ophthalmology. 141(2). 159–159. 10 indexed citations
11.
Puzniak, Laura, et al.. (2021). Real-world use of ceftolozane/tazobactam: a systematic literature review. Antimicrobial Resistance and Infection Control. 10(1). 68–68. 20 indexed citations
12.
Puzniak, Laura, et al.. (2021). Systematic Literature Review of Real-world Evidence of Ceftolozane/Tazobactam for the Treatment of Respiratory Infections. Infectious Diseases and Therapy. 10(3). 1227–1252. 12 indexed citations
13.
Enstone, Ashley, et al.. (2019). Real-world effectiveness and tolerability of small-cell lung cancer (SCLC) treatments: A systematic literature review (SLR). PLoS ONE. 14(7). e0219622–e0219622. 29 indexed citations
14.
Enstone, Ashley, et al.. (2017). The Economic Burden of Small Cell Lung Cancer: A Systematic Review of the Literature. PharmacoEconomics - Open. 2(2). 125–139. 12 indexed citations
15.
Enstone, Ashley, et al.. (2016). Structured Review of Health Economic Models in Asthma. Value in Health. 19(7). A372–A372. 1 indexed citations
16.
Dunlop, W., C. Daniel Mullins, Ron Goeree, et al.. (2016). BEACON: A Summary Framework to Overcome Potential Reimbursement Hurdles. PharmacoEconomics. 34(10). 1051–1065. 11 indexed citations
17.
Ding, Bo & Ashley Enstone. (2016). Asthma and chronic obstructive pulmonary disease overlap syndrome (ACOS): structured literature review and physician insights. Expert Review of Respiratory Medicine. 10(3). 363–371. 23 indexed citations
18.
Enstone, Ashley, et al.. (2015). Societal Burden And Impact On Health Related Quality Of Life (Hrqol) Of Non-Small Cell Lung Cancer (Nsclc) In Europe. Value in Health. 18(7). A690–A690. 3 indexed citations
19.
Hartz, Susanne, et al.. (2015). Elicitation of health state utilities associated with varying severities of flares in Systemic Lupus Erythematosus. Health and Quality of Life Outcomes. 13(1). 66–66. 5 indexed citations
20.
Hartz, S C, et al.. (2014). Elicitation of Health State Utilities Associated with Varying Severities of Flare in Systemic Lupus Erythematosus. Value in Health. 17(7). A331–A331. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuqian Chen Breakdown of academic impact, for papers by Shinya Hasegawa Breakdown of academic impact, for papers by Alejandro Martín‐Quirós Breakdown of academic impact, for papers by Benjamin Hetzer Breakdown of academic impact, for papers by Seungjae Lee Breakdown of academic impact, for papers by Davaalkham Dambadarjaa Breakdown of academic impact, for papers by Sae‐Rom Chae Breakdown of academic impact, for papers by José-Antonio Navarro-Alonso Breakdown of academic impact, for papers by Victor Perez-Gutierrez Breakdown of academic impact, for papers by Sarah Kristine Nørgaard
Rankless by CCL
2026